Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
What the Fly Forgot—Aβ Expression in Drosophila
8 April 2004. A transgenic Drosophila model of AD shows learning deficits, reduced lifespan, amyloid buildup, and neurodegeneration in response to expression of human Aβ42, as described in PNAS Early Edition. The human Aβ40 fragment produced a similar learning deficit without obvious pathology.

What does a fly have to forget, one might well ask? Granted, not the names of its grandchildren or the shopping list, but it can forget the simplest form of aversive Pavlovian conditioning. Senior author Yi Zhong and colleagues at Cold Spring Harbor Laboratory in New York, as well as at Nation Tsing Hua University in Hsinchu, Taiwan, and Novartis Pharamceuticals in Summit, New Jersey, paired certain odors with electric shocks, and tested the flies on their subsequent ability to avoid the "shocking" odor. Both Aβ40 and -42 expression produced deficits in flies by age 6 to 7 days, and these deficits grew by age 14 to 15 days. It appears, however, that greater amounts of Aβ40 expression were required to produce the learning deficits. The researchers were unable to test whether the deficits continued to grow after this age, because the Aβ42 flies, (though not the Aβ40 flies) showed a concurrent decline in locomotion.

In normal flies—and in Aβ40 flies—old-age mortality begins with a steep increase just after 60 days, and most flies are dead by 80 days of age. The Aβ42 transgenic flies began to die in large numbers after 40 days, with most dead by about 60 days.

Neurodegeneration detected by confocal microscopy began in a small way around age 30 in the Aβ42 flies, and became significant 15 days later. At 48 days, these transgenics had significant amyloid deposits. Neither neurodegeneration nor amyloid buildup was evident in Aβ40 flies even in very old age. Neither transgenic fly showed any evidence of abnormal tau buildup.

"It is remarkable to note that in an organism with a life span of 2–3 months, accumulation of Aβ42 induces the sequential progression of pathological symptoms resembling those in mouse AD models and AD patients. Intriguingly, the onset of learning defects by Aβ42 occurs much earlier than that of degeneration in the flies, similar to that observed in mouse AD models and AD patients," write the authors.

The results might be construed to support the notion that the mechanisms of AD learning and memory deficits are not directly associated with neurodegeneration, given that Aβ40 produced learning deficits without the neurodegeneration.—Hakon Heimer.

Reference:
Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y. Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's disease. Proc Natl Acad Sci U S A. 2004 Apr 6 [Epub ahead of print]. Abstract

 
Comments on News and Primary Papers
  Comment by:  Mark Cookson
Submitted 12 April 2004  |  Permalink Posted 12 April 2004

The generation and phenotyping of Aβ40- and Aβ42-specific Drosophila transgenic lines make a valuable contribution to identifying the differences between these two peptides. By showing that both Aβ40 and Aβ42 form oligomers, but that only Aβ42 is deposited into insoluble fractions and inclusion bodies, this study provides further evidence that Aβ42 has more amyloidogenic properties. However, this result is not that surprising, given that enhanced fibrillogenesis of the longer species has been reported many times. What is possibly surprising is that both forms, including the less fibrillogenic and less easily deposited Aβ40, cause a subtle learning disorder. Again, the Aβ42 flies showed a greater deficit than the Aβ40 flies, demonstrating that even if the two peptides are not qualitatively different, they do behave in a quantitatively different manner. Two additional phenotypes—an age-related loss of motor function and shortened lifespan—are measurable only in the Aβ fly lines. Although Iijima and colleagues plausibly argue that this means there are different mechanisms of...  Read more
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad